Alagille Syndrome: all 31 studies
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentRecruitingNCT07585097
- Pediatric Evaluation and Registry for Liver Cholestasis in CanadaRecruitingNCT07411716
- Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver TransplantationRecruitingNCT07335523
- A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)RecruitingNCT07293897
- Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)RecruitingNCT07290257Phase 4
- A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentRecruitingNCT06850038
- Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)RecruitingNCT06767605
- Dental Dyschromia and Quality of Life in Early Prolonged HyperbilirubinemiaRecruitingNCT06506734
- Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)RecruitingNCT06193928
- Decreasing Hemorrhage Risk in Children With Alagille SyndromeEnrolling by invitationNCT05846854Not applicable
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
- A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)CompletedNCT05543174Phase 3Results posted
- A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).CompletedNCT04729751Phase 2Results posted
- Efficacy and Safety of Odevixibat in Patients With Alagille SyndromeCompletedNCT04674761Phase 3Results posted
- Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)CompletedNCT02160782Phase 2Results posted
- An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille SyndromeCompletedNCT02117713Phase 2Results posted
- Evaluation of LUM001 in the Reduction of Pruritus in Alagille SyndromeCompletedNCT02057692Phase 2Results posted
- An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)CompletedNCT02047318Phase 2Results posted
- Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille SyndromeCompletedNCT01903460Phase 2Results posted
- Atorvastatin Therapy on Xanthoma in Alagille SyndromeCompletedNCT05488067Phase 4
- Long-term Safety and Efficacy of Odevixibat in Patients With Alagille SyndromeActive, not recruitingNCT05035030Phase 3
- Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary TuberculosisCompletedNCT04666311
- A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)Approved for marketingNCT04530994
- An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy SubjectsCompletedNCT03082937Phase 1
- A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedNCT02963077Phase 1
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)CompletedNCT02922751
- Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver DiseaseCompletedNCT02131623
- Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record ReviewCompletedNCT01515631
- Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)SuspendedNCT00571272
- Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver DiseaseCompletedNCT00007033Not applicable
- Positional Cloning of the Gene(s) Responsible for Alagille SyndromeCompletedNCT00001642